Chimerix Inc News - CMRX

Professional-Grade Tools, for Individual Investors.

Premium

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on January 17...

Chimerix to Speak Today at The White House Cancer Moonshot Forum

DURHAM, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

DURHAM, N.C., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose...

Small Cap Soars On FDA Submission Plans

A healthcare company based out of North Carolina is turning heads so far during Tuesday’s session after the company announced that it plans...

Form 8-K - Current report

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse Glioma Submission Plan Follows Productive and...

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on December 2...

Form 8-K - Current report

glenn1919 4 weeks ago

CMRX................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 4 weeks ago

cmrx...................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 1 month ago

cmrx..................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783

👍️0

bikaver 1 month ago

CMRX.....bought in @ 2.93.....could see another leg up!

👍️0

glenn1919 1 month ago

CMRX.........................................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 2 months ago

CMRX..............https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

🏦 1 ✅️ 1

Zardiw 2 months ago

$CMRX - Gain: 217% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

Z

👍️0

dablitz 2 months ago

Congrat's to those those who had a good day here today.

👍️0

Invest-in-America 2 months ago

CMRX: Another article about it ---
https://finance.yahoo.com/news/why-cancer-focused-chimerix-stock-143934294.html

👍️0

georgie18 2 months ago

CMRX...All out in the $3.10 range...🥳Beauty flip...from $2.02 range...

georgie18

Member Level
Re: georgie18 post# 667358

Tuesday, December 10, 2024 9:45:48 AM

Post#
667376
of 667379
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

👍️0

georgie18 2 months ago

CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

👍️0

georgie18 2 months ago

CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

👍️0

glenn1919 2 months ago

CMRX.............................https://stockcharts.com/h-sc/ui?s=CRMX&p=W&b=5&g=0&id=p86431144783

👍️ 1 💲 1

Invest-in-America 2 months ago

CMRX: Soaring!!! Likely $3-4 bucks in the Post-M!!!

👍️0

glenn1919 2 months ago

CMRX.......................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

👍️0

georgie18 2 months ago

CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

👍️0

georgie18 2 months ago

CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

👍 1

pzottkpz 2 months ago

⏰⏰⏰⏰⏰⏰⏰⏰⏰⏰

can this hold a buck if markets correct
or will they have to do something to maintain listing

💲CMRX

👍️0

Monksdream 5 months ago

CMRX new 52 week low

👍️0

mick 1 year ago

GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:

👍️0

mick 1 year ago

GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:

👍️0

Monksdream 1 year ago

CMRX new 52 low

👍️0

Monksdream 1 year ago

CMRX new 52 week low

👍️0

Monksdream 1 year ago

CMRX new 52 week low

👍️0

kzivann 2 years ago

Thanks, saw that but neglected to post news.

CMRX

👍️0

db7 2 years ago

https://www.businesswire.com/news/home/20221110005658/en/

👍️0

kzivann 2 years ago

More good news.

CMRX

👍️0

kzivann 2 years ago

News looks good.

CMRX

👍️0

kzivann 2 years ago

Nice news. Got some.

CMRX

👍️0

weedtrader420 2 years ago

WEEEEEEEEE

👍️0

weedtrader420 2 years ago

Monday fun here CMRX$ WOW! Monkey pox vaccine

👍️0

weedtrader420 2 years ago

weedtrader420 2 years ago

CMRX$

👍️0

db7 2 years ago

from the EBS earnings call transcript:

"
Unidentified Analyst

This is Nick on for Boris. So I just have a quick question about Chimerix and TEMBEXA. So previously, the -- right pretty much right after you guys announced this acquisition of TEMBEXA, they said that the BARDA contract was likely to take place within the next couple of weeks or months, and now it's pushed back. And I just wanted to know if you guys had any reasoning behind this or any information as to why it's been pushed back, especially with monkeypox and now being declared a public health emergency, you kind of think that it may be pushed forward, but it seems to be just pushed back a little bit more.

Bob Kramer

Yes. Thanks, Nick, for the question. Thanks for joining the call. So a couple of comments. As I commented on my prepared remarks, the HSR process and the waiting period for this expired last Friday. So now that, I think, gives BARDA and Chimerix kind of the green light to finalize the BARDA procurement agreement, which then gives us the clear path to closing the transaction and moving forward.

I wouldn't read anything into the perhaps perceived delay in getting the contract awarded. Obviously, BARDA is looking at this very carefully and they are aware that our interest in acquiring the product from Chimerix. So I think, again, there's momentum to get this done, and we're anxious to get done as well

"

👍️0

db7 2 years ago

my hope is that the BARDA negotiation is to 'upsize' the original contract that was discussed(?)

👍️0

weedtrader420 2 years ago

CMRX$$$$$$$$ WOOHOOOOOO

👍️0

weedtrader420 2 years ago

CMRX$ $5 TARGET

👍️0

weedtrader420 3 years ago

CMRX$Surfin USA

👍️0

db7 3 years ago

interesting if we get BARDA announcement this week; per last extension due 'soon'

👍️0

Trend22 3 years ago

CMRX - Nice news and nice pre market!

👍️0

weedtrader420 3 years ago

CMRX$

👍️0

weedtrader420 3 years ago

CMRX SIGA $$$$$$$$$$$$

👍️0

weedtrader420 3 years ago

CMRX$

👍️0

weedtrader420 3 years ago

Now we’re moving WOOHOOOOOO CMRX$$$$$$$$$$$$$$SIGA

👍️0

weedtrader420 3 years ago

CMRX SIGA Upchurch HI-DEAS 2 $$$$$$$$$$$

👍️0

weedtrader420 3 years ago

CMRX $10 TARGET PRICE WOOHOOOOOO

👍️0

weedtrader420 3 years ago

BUYING BUYING BUYING

👍️0

weedtrader420 3 years ago

CMRX$

👍️0

weedtrader420 3 years ago

Monkeypox is spreading all over America

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Chimerix Inc (CMRX)

Professional-Grade Tools, for Individual Investors.

CMRX News

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chimerix to Speak Today at The White House Cancer Moonshot Forum

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

Small Cap Soars On FDA Submission Plans

Form 8-K - Current report

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

CMRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Chimerix Inc (CMRX) News

Chimerix Inc (CMRX)

Professional-Grade Tools, for Individual Investors.

CMRX News

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chimerix to Speak Today at The White House Cancer Moonshot Forum

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

Small Cap Soars On FDA Submission Plans

Form 8-K - Current report

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

CMRX Discussion

Your Recent History

Go Ad-Free